Dysfunctioning of the heart forms part of the multiple organ dysfuncti
on syndrome (MODS) in sepsis and SIRS. This acute septic cardiomyopath
y is often underestimated in degree and relevance, although yet in fac
t 10% of all sepsis fatalities are due to intractable heart failure. T
his potentially reversible cardiomyopathy is characterized by a consid
erable pump failure, is not primarily ischemic, coronary blood flow be
ing normal or even enhanced; left and right ventricle are enlarged as
a consequence of an increased ventricular compliance. Damage of the he
art can further be aggravated in case of an additional right ventricul
ar impairment due to pulmonary hypertension in ARDS. SIRS-cardiomyopat
hy in noninfectious MODS has common traits with acute septic cardiomyo
pathy. The pathogenesis of heart disease in sepsis and SIRS is multifa
ctorial, the ''endotoxin/TNF-alpha/NO/cGMP-cascade representing a main
negative inotropic axis. Therapy of acute septic cardiomyopathy and S
IRS-cardiomyopathy at present still is mainly symptomatic (volume subs
titution, inotropic/vasoactive agents), causal therapeutic principles
are, however, put to test in the context of a comprehensive concept of
causal sepsis treatment.